10.1111/febs.15772
Reduction of DHT: GHK-Cu, when combined with other peptides, can inhibit 5-alpha-reductase, the enzyme that converts testosterone into DHTa key contributor to male pattern baldness
This unique position allows it to work at the frontline of cellular defense, directly neutralizing harmful free radicals before they can damage your DNA, proteins, and cell membranes
This delayed-release formula features Salcaprozate Sodium (SNAC) to help optimize absorption and ingredient delivery
Bloom R, Amber KT (2017) Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials
The Klow peptide formulation is a research-grade composite blend that combines four bioactive peptides: BPC 157 peptide, GHK CU peptide, TB500 peptide, and KPV peptide